1. MicroRNA-675-3p regulates IL-1β-stimulated human chondrocyte apoptosis and cartilage degradation by targeting GNG5
- Author
-
Yi Cheng, Xiao-Fei Shen, Qirong Dong, and Min-Qian Zheng
- Subjects
0301 basic medicine ,Protein subunit ,Interleukin-1beta ,Biophysics ,Apoptosis ,Biochemistry ,Chondrocyte ,03 medical and health sciences ,Chondrocytes ,0302 clinical medicine ,GTP-Binding Protein gamma Subunits ,Osteoarthritis ,microRNA ,medicine ,Humans ,Molecular Biology ,Cells, Cultured ,Inflammation ,Messenger RNA ,Cell growth ,Chemistry ,Cell Biology ,Long non-coding RNA ,Up-Regulation ,Cell biology ,MicroRNAs ,Cartilage ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,XIST - Abstract
Growing evidence has indicated that microRNAs (miRNAs) are modulators of osteoarthritis (OA) development and progression. In this study, we first evaluated the anti-apoptosis and chondroprotective effects of microRNA-675-3p (miR-675-3p) on interleukin-1β (IL-1β)-stimulated human chondrocytes. The overexpression of miR-675-3p inhibited apoptosis and cartilage matrix degradation and promoted cell proliferation in human chondrocytes. Target gene prediction and luciferase reporter assays suggested that G-protein subunit γ 5 (GNG5) may be the target gene of miR-675-3p. The overexpression of miR-675-3p inhibited IL-1β-stimulated chondrocyte apoptosis, and this effect was reversed by the overexpression of GNG5. Finally, we used bioinformatic tools and biological methods to show that the long noncoding RNA X-inactive specific transcript (lncRNA XIST) could bind to miR-675-3p, which affects the expression of GNG5 mRNA. Our findings may substantiate miR-675-3p as a new treatment for OA.
- Published
- 2020
- Full Text
- View/download PDF